Stephen V Liu

Malak Alharbi: Stephen V. Liu discusses treatment algorithm for early-stage NSCLC

Malak Alharbi, Hematology/Oncology Fellow at Roswell Park, made the following post on X:

“Dr. Stephen V. Liu discussed treatment algorithm for early-stage NSCLC.

1. Is pCR a surrogate marker for better overall survival in lung cancer??

2. Most important steps; determining respectability & testing for driving mutations.”

Malak Alharbi: Stephen V. Liu discusses treatment algorithm for early-stage NSCLC

Source: Malak Alharbi/X

cancer Dr. Stephen V. Liu driving mutations early stage NSCLC Hematology/Oncology Fellow Lung cancer lung cancer research Malak Alharbi OncoDaily Oncology overall survival pCR resectability Roswell Park surrogate marker treatment algorithm